Avadel Pharmaceuticals PLC Cash Flow Reinvestment Rate
Avadel Pharmaceuticals PLC cash flow reinvestment rate. Avadel Pharmaceuticals PLC (AVDL) has a Cash Flow Reinvestment Rate of 0.36x as of September 2025, reinvesting $8.44 Million (capex $10.76K plus investments $-8.43 Million) from operating cash flow of $23.26 Million. See AVDL financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Avadel Pharmaceuticals PLC (2002–2017)
Cash flow reinvestment rate of Avadel Pharmaceuticals PLC from 2002 to 2017. Historical reinvestment intensity for Avadel Pharmaceuticals PLC across 6 annual periods. Explore AVDL debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Avadel Pharmaceuticals PLC Cash Flow Reinvestment Rate by Year (2002–2017)
Avadel Pharmaceuticals PLC cash flow reinvestment rate by year from 2002 to 2017. Year-by-year capital reinvestment analysis for Avadel Pharmaceuticals PLC. For the full cash flow conversion analysis, see how efficiently does Avadel Pharmaceuticals PLC generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 5.50x | $91.71 Million | $16.66 Million | $53.70 Million | ▲ +179.2% |
| 2016 | 1.97x | $37.26 Million | $18.90 Million | $1.20 Million | ▲ +423.7% |
| 2015 | 0.38x | $31.73 Million | $84.29 Million | $1.63 Million | ▲ +74.3% |
| 2009 | 0.22x | $1.77 Million | $8.20 Million | $1.77 Million | ▼ -7.0% |
| 2003 | 0.23x | $2.84 Million | $12.23 Million | $2.84 Million | ▲ +42.0% |
| 2002 | 0.16x | $1.44 Million | $8.77 Million | $1.44 Million | — |